HOME >> BIOLOGY >> NEWS
16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

The 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics brings 2,000 international cancer experts together to present new data on leading-edge basic, translational and early clinical research.

News briefing:

12.30 hrs CET Wednesday 29 September:

Speakers and topics

    * Dr Monika Hegi: Trial identifies which brain cancer patients benefit from temozolomide: genetic predictive test can be carried out in any laboratory and means temozolomide can now become a targeted treatment.

    * Dr Ardeshir Ghavamzadeh: Trial results indicate arsenic should now be considered first-line treatment for one type of leukaemia

    *Dr Kim Chi: Successful results of Phase I trial of the first second generation antisense cancer drug - phase II getting under way

    * Dr Grant McArthur: Award winning researcher reveals potential new role for Glivec in a soft tissue cancer

Chairman: Professor Jaap Verweij (EORTC chairman of conference scientific committee) together with scientific committee co-chairmen Dr Janet Dancey (NCI) and Dr Eric K Rowinsky (AACR)

NB: any reports involving the topics outlined above are embargoed until the time and date of the news briefings.

Journalists wishing to dial in to the news briefing should contact Margaret Willson by Friday 25 September.

More information:

Margaret Willson
Conference Press Officer

Tel: 44-153-677-2181 (office)
44-797-385-3347 (mobile)
Email: m.willson@mwcommunications.org.uk

Conference media centre:
From 16.00 hrs CET Monday 27 September to 17.00 hrs CET Friday 1 October
Tel: 41-22-761-2205
Fax: 41-22-761-2211


'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-015-367-72181
European Organisation for Research and Treatment of Cancer
22-Sep-2004


Page: 1

Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
3. Health of worlds sea lions the focus of Wakefield Symposium
4. Chemical signals health of brain cells Symposium
5. Final Alert: 16th EORTC NCI AACR Symposium
6. 16th EORTC NCI AACR Symposium
7. Symposium to tackle questions of genetic engineering and biodiversity
8. Fostering Diversity in the Sciences Symposium
9. Annual Chemical Biology Symposium at Yale May 14, 2004
10. Symposium relates long-term ecological research to ecosystem management
11. Symposium examines the growing influence of aerosols on climate

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/5/2019)... Calif. (PRWEB) , ... July 05, 2019 , ... ... with Microsoft to bring its patented Tractus™ Platform to governments around the world. ... bring cutting edge technology and point of care solutions to operating theatres worldwide ...
(Date:6/20/2019)... ... June 19, 2019 , ... The half-million dollars ... of America Foundation, and the possibly millions of dollars of “high priority” grants ... AD, are a “welcome affirmation” of the need to investigate more thoroughly the ...
(Date:6/16/2019)... ... , ... Emtec, Inc.®, a global IT and management consulting ... CIO at the Healthcare Industry User Group (HIUG) Interact 2019 in ... President and Chief Information Officer, Lynne Briggs, will present Versiti’s Oracle Cloud Success ...
Breaking Biology News(10 mins):
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine ... Pharm: Where Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as ... Animal Pharm was recently included in the Brentwood and Pacific Palisades International ...
(Date:6/12/2019)... TOWNSHIP, N.J. (PRWEB) , ... June 12, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... with Shanghai Zillion has been signed. The agreement will grant exclusive rights for ...
(Date:6/11/2019)... ROANOKE, Va. (PRWEB) , ... June 11, 2019 ... ... for microlearning engagement, and Carilion Clinic, a national leader in opioid treatment, announced ... in virtual care. , Mytonomy recently deployed its virtual care platform ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, radiation ... have led to the advent of Chimeric Antigen Receptor T (CAR T) cell therapy, ... “CARs”. The CAR enables the final product to produce chemicals in the hopes that ...
Breaking Biology Technology:
Cached News: